Inspire Medical Systems Inc (INSP)

Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell

$133.20

Buy

$134.43

arrow-down$-4.47 (-3.23%)

Prices updated at 02 Jun 2025, 22:37 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Inspire Medical Systems Inc operates as a medical technology company. The firm develops implantable neurostimulation systems to treat obstructive sleep apnea.
S&P 500
arrow-up0.41%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. Timothy P. Herbert
CEO
Mr. Timothy P. Herbert
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
1,246
Head office
5500 Wayzata Boulevard
Golden Valley
United States
55416
mobile
+1 844 672-4357
letter
Bob@LifeSciAdvisors.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Mr. Bryan K. Phillips
Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
0.43m
Mr. Gary L. Ellis
Lead Independent Director
0.09m
Mr. Dana G. Mead, Jr
Independent Director
0.07m
Mr. Shawn T. McCormick
Independent Director
0.07m
Ms. Shelley G. Broader
Independent Director
0.07m
Mr. Casey M. Tansey
Independent Director
0.06m
Dr. Myriam J. Curet, F.A.C.S.,M.D.
Independent Director
0.06m
Mr. Randall A. Ban
Executive Vice President, Patient Access and Therapy Development
0.47m
Mr. Richard J. Buchholz
Chief Financial Officer and Principal Accounting Officer
0.46m
Mr. Timothy P. Herbert
Chief Executive Officer, President and Chairman of the Board
0.73m
Ms. Georgia Garinois-Melenikiotou
Independent Director
0.06m
Mr. John C. Rondoni
Chief Technology Officer
-
Ms. Cynthia B. Burks
Independent Director
0.06m
Mr. Carlton W. Weatherby
Chief Strategy Officer and Chief Growth Officer
0.47m
Ms. Melissa Mann
Chief People Officer
-
Mr. Jason P. Kelly
Chief Manufacturing and Chief Quality Officer
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
BlackRock, Inc.4,118,053
BlackRock Inc4,029,559
Vanguard Group Inc3,225,645
Vanguard Group Inc. ( Junked)3,232,138
FMR LLC2,927,815

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
20 Dec 2024-
20 Dec 2024-
20 Dec 2024-
20 Dec 2024-
20 Dec 2024-
01 Nov 2024-
01 Nov 2024-
01 Nov 2024-
01 Nov 2024-
01 Nov 2024-
01 Nov 2024-
01 Nov 2024-
01 Nov 2024-
14 Oct 2024-
14 Oct 2024-
14 Oct 2024-
14 Oct 2024-
09 Sep 2024-
09 Sep 2024-
22 Aug 2024-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.